Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial

BACKGROUND: Pacemakers are widely utilised to treat bradycardia, but right ventricular (RV) pacing is associated with heightened risk of left ventricular (LV) systolic dysfunction and heart failure. We aimed to compare personalised pacemaker reprogramming to avoid RV pacing with usual care on echoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Paton, Maria F., Gierula, John, Lowry, Judith E., Cairns, David A., Bose Rosling, Kieran, Cole, Charlotte A., McGinlay, Melanie, Straw, Sam, Byrom, Rowena, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668131/
https://www.ncbi.nlm.nih.gov/pubmed/34898655
http://dx.doi.org/10.1371/journal.pone.0259450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668131/
https://www.ncbi.nlm.nih.gov/pubmed/34898655
http://dx.doi.org/10.1371/journal.pone.0259450

Ejemplares similares